Precision Therapeutics Inc.
|
|
|
|
|
commercializing its ChemoFx chemo-sensitivity/resistance assay (CSRA). The assay uses ex-vivo testing of chemotherapeutic agents on a tumor specimen to help oncologists choose among therapy options when multiple different regimens are available | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|